姓名：曹邦伟 性别：男 职称：主任医师、教授 招生院所：附属友谊医院 招生类型：科学与专业学位(博) 科学与专业学位(硕) 招生专业：肿瘤学(博) 肿瘤学(硕) 研究方向名称：恶性肿瘤的诊断与治疗 电子信箱：oncology@ccmu.edu.cn


社会任职
1. 《中国医院用药评价与分析》杂志副主编
2. 首都医科大学肿瘤学系副主任
3. 北京市食管癌早癌防治重点实验室副主任
4. 北京市肿瘤治疗质量控制和改进中心委员
5. 北京中医药学会肿瘤专业委员会常委
个人简历
1. 200009-200507:北京大学临床肿瘤学院 学习
2. 200508-200909:北京大学第一医院 副主任医师
3. 200910-:首都医科大学附属北京友谊医院 主任医师
4. 201402-:首都医科大学附属北京友谊医院 主任医师 教授
重要学术论文
1. Zhao L, Wang J, Li H, Che J, Ma N, Cao Bangwei*.Safety and Efficacy of Tianfoshen Oral Liquid in Non-Small Cell Lung Cancer Patients as an Adjuvant Therapy.. Evid Based Complement Alternat Med. 209,2019:**:doi: 10.1155/2019/**.SCI
2. Lian X, Zhu C, Lin H, Gao Z, Li G, Zhang N, Cao Bangwei*, Kang Y..Radiosensitization of HER2-positive esophageal cancer cells by pyrotinib.. Biosci Rep.. 2020,40(2):pii: BSR**.SCI
3. Zhao L, Yu J, Wang J, Li H, Che J, Cao Bangwei*.Risk of immune-related diarrhea with PD-1/PD-L1 inhibitors in different cancer types and treatment regimens.. J Cancer. 2020,11(1):41-50..SCI
4. Zhang N, Ren Y, Wang Y, Zhao L, Wang B, Ma N, Gao Z, Cao Bangwei*.LRG1 Suppresses Migration and Invasion of Esophageal Squamous Cell Carcinoma by Modulating Epithelial to Mesenchymal Transition.. J Cancer. 2020,11(6):1486-1494.SCI
5. Ma Y, Yu J, Li Q, Su Q, Cao Bangwei*.Addition of docosahexaenoic acid synergistically enhances the efficacy of apatinib for triple-negative breast cancer therapy.. Biosci Biotechnol Biochem.. 2020,84(4):743-756.SCI
6. Gao Z, Song C, Li G, Lin H, Lian X, Zhang N, Cao Bangwei*.Pyrotinib treatment on HER2-positive gastric cancer cells promotes the released exosomes to enhance endothelial cell progression, which can be counteracted by apatinib.. Onco Targets Ther. 2019,11(12):2777-2787.SCI
7. Li G, Lin H, Tian R, Zhao P, Huang Y, Pang X, Zhao L, Cao Bangwei*. .VEGFR-2 Inhibitor Apatinib Hinders Endothelial Cells Progression Triggered by Irradiated Gastric Cancer Cells-derived Exosomes. . J Cancer. 2018,9(21):4049-4057.SCI
8. Lin H, Wang B, Yu J, Wang J, Li Q, Cao Bangwei*.Protein arginine methyltransferase 8 gene enhances the colon cancer stem cell (CSC) function by upregulating the pluripotency transcription factor.. J Cancer . 2018,9(8):1394-1402.SCI
9. Li T, Yu J, Luo X, Ren W, Zhang Y, Cao Bangwei*.VEGFR-2 as a novel predictor of survival in gastric cancer: A systematic review and meta-analysis
. Pathol Res Pract. 2018,214(4):560-564.SCI
10. Wu J, Yu J, Wang J, Zhang C, Shang K, Yao X, Cao Bangwei*.Astragalus polysaccharide enhanced antitumor effects of Apatinib in gastric cancer AGS cells by inhibiting AKT signalling pathway. Biomed Pharmacother. 2018,100:176-183.SCI
11. Che J, Yue D, Zhang B, Zhang H, Huo Y, Gao L, Zhen H, Yang Y, Cao Bangwei*.Claudin-3 Inhibits Lung Squamous Cell Carcinoma Cell Epithelial-mesenchymal Transition and Invasion via Suppression of the Wnt/β-catenin Signaling Pathway. Int J Med Sci. 2018,15(4):339-351.SCI
12. Li G, Lin H, Tian R, Zhao P, Huang Y, Pang X, Zhao L, Cao Bangwei*.VEGFR-2 Inhibitor Apatinib Hinders Endothelial Cells Progression Triggered by Irradiated Gastric Cancer Cells-derived Exosomes. . J Cancer.. 2018,9(21):4049-4057.SCI
13. Li X, Xu A, Li H, Zhang B, Cao Bangwei*, Huang J*.Novel role of apatinib as a multi-target RTK inhibitor in the direct suppression of hepatocellular carcinoma cells.. Biochim Biophys Acta. 2018,1864(5 Pt A):1693-1701.SCI
14. Li H, Fan Y, Yang F, Zhao L, Cao Bangwei*.The coordinated effects of Apatinib and Tripterine on the proliferation, invasiveness and apoptosis of human hepatoma Hep3B cells. . Oncol Lett.. 2018,16(1):353-361.SCI
15. Lin H, Yang G, Yu J, Wang J, Li Q, Guo S*, Cao Bangwei*. .KDM5c inhibits multidrug resistance of colon cancer cell line by down-regulating ABCC1. . Biomed Pharmacother. 2018,107:1205-1209.SCI
16. Lin H, Wang B, Yu J, Wang J, Li Q, Cao Bangwei*..Protein arginine methyltransferase 8 gene enhances the colon cancer stem cell (CSC) function by upregulating the pluripotency transcription factor.. J Cancer. 2018,9(8):1394-1402..SCI
17. Li Q, Li L, Jiang X, Du Q, Li Y, Li T, Gong H, Cao Bangwei*.Characteristics and prognostic values of traditional pathological parameters and advanced molecular subtypes in women in Beijing with operable breast cancer: a retrospective analysis. . BMJ Open. 2018,8(11):e021819.SCI
18. Wu J, Wang J, Su Q, Ding W, Li T, Yu J, Cao Bangwei*.Traditional Chinese medicine Astragalus polysaccharide enhanced antitumor effects of the angiogenesis inhibitor apatinib in pancreatic cancer cells on proliferation, invasiveness, and apoptosis. . Onco Targets Ther. 2018,11:2685-2698.SCI
19. Zhao L, Yu J, Wang J, Li H, Che J,Cao Bangwei*.Isolation and Identification of miRNAs in exosomes derived from serum of colon cancer patients. J Cancer. 2017,8(7):1145-1152.SCI
20. Zhao L, Leung LH, Wang J, Li H, Che J, Liu L, Yao X, Cao Bangwei*.Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer. BMC Pulm Med. 2017,17(1):112.SCI
21. Geng F, Wang Z, Yin H, Yu J,Cao Bangwei*.Molecular Targeted Drugs and Treatment of Colorectal Cancer: Recent Progress and Future Perspectives. Cancer Biother Radiopharm. 2017,32(5):149-160.SCI
22. Yu J, Che J, Liu L, Yang F, Zhu X, Cao Bnagwei*..Tetrahydropalmatine attenuates irradiation induced lung injuries in rats.. Life Sci.. 2016,3205(16):30202-8.SCI
23. Li Q, Zhang L, Li X, Yan H, Yang L, Li Y, Li T, Wang J, Cao Bangwei*..The prognostic significance of human epidermal growth factor receptor family protein expression in operable pancreatic cancer : HER1-4 protein expression and prognosis in pancreatic cancer.. BMC Cancer.. 2016,21;16(1):910.SCI
24. Wang J, Zhao L, Yan H, Che J, Huihui L, Jun W, Liu B, Cao Bangwei*..A Meta-Analysis and Systematic Review on the Association between Human Papillomavirus (Types 16 and 18) Infection and Esophageal Cancer Worldwide.. PLoS One. 2016,11(7):e**.SCI
25. Zhao L, Wang J, Li H, Che J,Cao Bangwei*..Meta-analysis comparing maintenance strategies with continuous therapy and complete chemotherapy-free interval strategies in the treatment of metastatic colorectal cancer.. Oncotarget. 2016,7(22):33418-28.SCI
26. Zhao L, Liu W, Xiao J, Cao Bangwei*.The role of exosomes and "exosomal shuttle microRNA" in tumorigenesis and drug resistance.. Cancer Lett.. 2015, 28;356(2PtB):339-346.SCI
27. Ma YJ, Yu J, Xiao J, Cao Bangwei*.The consumption of omega-3 polyunsaturated Fatty acids improves clinical outcomes and prognosis in pancreatic cancer patients: a systematic evaluation. Nutr Cancer.. 2015,67(1):112-118 .SCI
28. Yu J, Xiao J, Yang Y, Cao Bangwei*.Oxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer. Medicine (Baltimore). 2015,94(27):e1072.SCI
29. Li Q, Yan H, Zhao P, Yang Y, Cao Bangwei*.Efficacy and Safety of Bevacizumab Combined with Chemotherapy for Managing Metastatic Breast Cancer: A Meta-Analysis of Randomized Controlled Trials. Sci Rep. 2015,(5)15746:15746.SCI
30. Che J, Yang Y, Xiao J, Zhao P, Yan B, Dong S, Cao Bangwei*.Decreased expression of claudin-3 is associated with a poor prognosis and EMT in completely resected squamous cell lung carcinoma. Tumour Biol. 2015,36(8):6559-68.SCI
31. Yan H, Li Q, Wang W, Zhen H, Cao Bangwei*.Systems assessment of intercalated combination of chemotherapy and EGFR TKIs versus chemotherapy or EGFR TKIs alone in advanced NSCLC patients. Sci Rep. 2015,(5)15355:15355.SCI
32. Yan H, Li H, Li Q, Zhao P, Wang W, Cao Bangwei*.The Efficacy of Synchronous Combination of Chemotherapy and EGFR TKIs for the First-Line Treatment of NSCLC: A Systematic Analysis. PLoS One. 2015,10(8):e**.SCI
33. Li H, Zhen H, Han L, Yan B, Yu J, Zhu S, Cao Bangwei*.Association between the genetic variations within TBX21 gene promoter and the clinicopathological characteristics of esophageal squamous cell carcinoma in a high-risk Chinese population.. Tumour Biol. 2015,36(5):3985-93.SCI
34. Li Q, Yuan Z, Yan H, Wen Z, Zhang R, Cao Bangwei*.Comparison of gemcitabine combined with targeted agent therapy versus gemcitabine monotherapy in the management of advanced pancreatic cancer. Clin Ther.. 2014,36(7):1054-1063.SCI
35. Li Q, Yan H, Liu W, Zhen H, Yang Y, Cao Bangwei*.Efficacy and safety of gemcitabine-Fluorouracil combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomized controlled trials. PLoS One. . 2014,9(8):e104346.SCI
36. Song L, Ma N, Han L, Yan H, Yan B, Yuan Z, Cao Bangwei*.Association between LMP2/LMP7 genetic variability and the metastasis risk of ovarian cancer in Chinese women in Beijing.. Hum Immunol.. 2014,75(3):239-44.SCI
37. Li Q, Yuan Z, Cao Bangwei.*.The function of human epidermal growth factor receptor-3 and its role in tumors (Review). Oncol Rep. 2013,30(6):2563-70.SCI
38. Yu J, Zhu X, Qi X, Che J, Cao Bangwei*.Paeoniflorin protects human EA.hy926 endothelial cells against gamma-radiation induced oxidative injury by activating the NF-E2-related factor 2/heme oxygenase-1 pathway.. Toxicology letters. 2013,218(3):224-234.SCI
39. Cao Bangwei, Dong S, Su Q, Yan B, Zhen H, Yuan Z, Liu X, Li Y..Lack of association between the unique LMP2 gene polymorphism and the outcome of lung cancer in a population of Chinese Han nationality. . Human immunology. 2012,73 (5):580–584.SCI
40. Cao Bangwei, Zhu L, Zhu S, Li D, Zhang C, Xu C, Zhang S.Genetic variations and haplotypes in TIM-3 gene and the risk of gastric cancer. Cancer Immunol Immunother. 2010,59（12）:1851-1857.SCI
41. Hou R, Cao Bangwei#, Chen Z, Li Y, Ning T, Li C, Xu C, Chen Z*.Association of cytotoxic T lymphocyte-associated antigen-4 gene haplotype with the susceptibility to gastric cancer. Molecular biology reports. 2010,37(1):515-520.SCI
42. Cao Bangwei, Liu X, Hou F, Li W, Han Z, Zhang Q, Dai Y, Xu C, Qi H*.The haplotype of the MxA gene promoter is associated with hepatitis B virus infection in a Chinese population. Liver International. 2009,29(9):1383-1388.SCI
43. Xu C, Qi S, Gao L, Cui H, Liu M, Yang H, Li K, Cao Bangwei*.Genetic polymorphisms of LMP/TAP gene and hepatitis B virus infection risk in the Chinese population. Journal of Clinical Immunology. 2007,27(5):534-541.SCI
44. Cao Bangwei, Yang H, Ding H, Qi S, Gao L, Cui H, Dai Y, Xu C*.Association analysis of hepatitis virus B infection with haplotypes of the TBX21 gene promoter region in the Chinese population. Clinical Chemistry and Laboratory Medicine . 2007,45(3):333-338.SCI
45. Liu M, Cao Bangwei#, Zhang H, Dai Y, Liu X, Xu C*.Association of interferon-gamma gene haplotype in the Chinese population with hepatitis B virus infection. Immunogenetics. 2006,58(11):859-864.SCI
46. Qi S, Cao Bangwei#, Jiang M, Xu C, Dai Y, Li K, Wang K, Ke Y, Ning T*.Association of the -183 polymorphism in the IFN- gene promoter with hepatitis B virus infection in the Chinese population. Journal of Clinical Laboratory Analysis. 2005,19(6):276-281.SCI
47. Cao Bangwei, Tian X, Li Y, Jiang P, Ning T, Xing H, Zhao Y, Zhang C, Shi X, Chen D, Shen Y, Ke*.LMP7/TAP2 gene polymorphisms and HPV infection in esophageal carcinoma patients from a high incidence area in China. Carcinogenesis. 2005,26(7):1280-1284.SCI
主编或副主编的著作/译著
1. 《北京友谊医院肿瘤科疾病病例精解》,主编,科学技术文献出版社,201910
2.
3. 《援疆实用肿瘤内科手册》,主编,北京大学医学出版社,201309
4. 《贝塞斯达临床肿瘤学手册》,主译,科学出版社,201203
5. 《援疆实用内科手册》,副主编,人民卫生出版社,201109
重要奖项